Targeted Therapies Beneficial in KRAS-Mutated NSCLC
Improved progression-free survival for patients treated with therapy not containing erlotinib
Sickle Cell Trait Doesn’t Up Mortality Risk in U.S. Soldiers
However, SC trait was linked with significantly higher risk of exertional rhabdomyolysis
Opioid-Related Insurance Claims Rise 3,000 Percent
Present crisis disproportionately affecting white, middle-class people in non-urban settings
Predictors ID’d for Switching to Active Tx in Prostate Cancer
Ethnicity influences patient decision to pursue active treatment and serial biopsies in active surveillance
Increasing Prevalence of Obesity in Cancer Survivors
Estimated rate of annual increase in obesity prevalence higher for adults with history of cancer
ASBS: Contralateral Prophylactic Mastectomy Discouraged
For most women, risk of disease in unaffected breast is low, American Society of Breast Surgeons says
July 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for July 2016. This roundup includes...
European Countries Implementing Cost-Sharing
Some financial protections are in place for poorer populations
Online Communication Tied to Positive Appraisal of Tx Decisions
More frequent online users more positively appraise their decision making in breast cancer
Esophageal Cancer Risk Raised by Alcohol Intake, Obesity
Third of cases may be avoided if people maintain a healthy weight and limit alcohol consumption
